{Reference Type}: Case Reports
{Title}: SMARCB1(INI-1)-Deficient Sinonasal Carcinoma: An Evolving Entity.
{Author}: Chung SY;Kenee P;Mitton T;Halderman A;
{Journal}: J Neurol Surg Rep
{Volume}: 84
{Issue}: 1
{Year}: Jan 2023
暂无{DOI}: 10.1055/a-1996-1283
{Abstract}: SMARCB1(INI-1)-deficient sinonasal carcinoma is a rare, poorly differentiated neoplasm with a poor prognosis. Though historically most were identified as sinonasal undifferentiated carcinoma, we now understand it to be a distinct entity. There is currently a general consensus supporting multimodal therapy, though the optimal sequence of surgery, chemotherapy, and radiation has yet to be defined.